knowledge -WSS

knowledge

author：fashion 2025-09-27 10:02:57 - browse：4783

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Medicare Advantage isn’t working — for anyone

focus

WSS

Medicare Advantage coverage denials need scrutiny, senators say

FDA early review: GLP

Fauci's latest grilling in Congress: 9 hours, behind closed doors

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Doctor of U.S. President Joe Biden says he is fit for duty

entertainment

knowledge

focus

Jerome Adams on the need for new antivirals for Covid

Ohio train derailment: Experts on toxic chemical risks

Supreme Court strikes down use of affirmative action

CDC advisory group OKs chikungunya vaccine

BioMarin wins approval for gene therapy to treat hemophilia A

Hospital chaplains balance Covid safety with patients’ spiritual needs

State Dept. review finds Biden bears some blame for Afghanistan failures

Ohio train derailment: Experts on toxic chemical risks

Anesthesiologist group: stop taking Ozempic before surgery

Children’s Hospital revives plan for pedestrian bridge

focus

Redefining sustainability for the pharmaceutical industry

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Using force crossed my mind when examining a defiant young patient

Hospital chaplains balance Covid safety with patients’ spiritual needs

Boston Scientific acquires urology company Axonics for $3.7 billion

Stories you might have missed in 2023: health, science, medicine

focus

hotspot

entertainment

explore